相似文献
1
Clinical testing of new antimalarial compounds.
Bull World Health Organ. 1974;50(3-4):203-12.
2
Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs.
Am J Trop Med Hyg. 1978 Jul;27(4):718-37. doi: 10.4269/ajtmh.1978.27.718.
3
Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int. 2002 Oct;11(61):131-6.
4
New perspectives on the chemotherapy of malaria, filariasis, and leprosy.
Prog Drug Res. 1974;18:99-172. doi: 10.1007/978-3-0348-7087-0_10.
5
Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090).
Antimicrob Agents Chemother. 1973 Feb;3(2):224-7. doi: 10.1128/AAC.3.2.224.
6
Resistance to antimalarial compounds: methods and applications.
Drug Resist Updat. 2009 Feb-Apr;12(1-2):42-50. doi: 10.1016/j.drup.2009.01.001. Epub 2009 Mar 13.
7
[Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria].
Med Parazitol (Mosk). 1976 Nov-Dec;45(6):731-7.
8
Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents.
Bioorg Med Chem. 2005 Nov 15;13(22):6226-32. doi: 10.1016/j.bmc.2005.06.052. Epub 2005 Jul 28.
9
Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents.
Exp Parasitol. 1993 Jun;76(4):345-51. doi: 10.1006/expr.1993.1042.
10
Progress in malaria chemotherapy. 1. Repository antimalarial drugs.
Prog Drug Res. 1969;13:170-216. doi: 10.1007/978-3-0348-7068-9_4.
引用本文的文献
1
Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.
Cell Mol Life Sci. 2012 Jun;69(12):1967-95. doi: 10.1007/s00018-011-0906-0.
2
Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.
Antimicrob Agents Chemother. 1993 Jul;37(7):1417-9. doi: 10.1128/AAC.37.7.1417.
3
New tissue schizontocidal antimalarial drugs.
Bull World Health Organ. 1981;59(3):463-79.
4
Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria.
Bull World Health Organ. 1974;51(4):375-7.
5
Antimalarial activities and subacute toxicity of RC-12, a 4-amino-substituted pyrocatechol.
Antimicrob Agents Chemother. 1985 Nov;28(5):612-25. doi: 10.1128/AAC.28.5.612.
6
Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine.
Eur J Clin Pharmacol. 1991;41(2):161-4. doi: 10.1007/BF00265910.
7
Suppressive activity of mefloquine in sporozoite-induced human malaria.
Antimicrob Agents Chemother. 1976 Mar;9(3):384-6. doi: 10.1128/AAC.9.3.384.
8
The treatment of malaria.
Br Med J. 1976 Feb 7;1(6005):323-8. doi: 10.1136/bmj.1.6005.323.
本文引用的文献
1
Agranulocytosis due to dapsone.
Ann Intern Med. 1970 Apr;72(4):521-4. doi: 10.7326/0003-4819-72-4-521.
2
The effects of diaphenylsulfone (DDS) against chloroquine-resistant Plasmodium falciparum.
Bull World Health Organ. 1966;34(5):671-81.
3
The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.
Bull World Health Organ. 1966;35(2):165-79.
4
Prophylaxis of malaria in man using the sulfones DFD and DDS alone and with chloroquine.
Mil Med. 1971 Nov;136(11):836-41.
5
Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man.
Mil Med. 1970 Jul;135(7):527-36.
6
Malaria chemoprophylaxis with 4,4' diaminodiphenylsulfone (DDS). II. Field trial with comparison between two divisions.
Mil Med. 1969 Jul;134(7):497-501.
7
8
The army malaria research program.
Ann Intern Med. 1969 Jan;70(1):150-3. doi: 10.7326/0003-4819-70-1-150.
9
10
Trimethoprim in therapy of acute attacks of malaria.
J Clin Pharmacol J New Drugs. 1967 Nov-Dec;7(6):336-41. doi: 10.1002/j.1552-4604.1967.tb00076.x.
Zotero 插件